Breast Cancer Surveillance in Women with Hereditary Risk Due to BRCA1 or BRCA2 Mutations
Screening of Women with Hereditary Risk of Breast Cancer
Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial
Internal Mammary Node Drainage and its Role in Sentinel Lymph Node Biopsy: The Initial ALMANAC Experience
“Ultrastaging” of Breast Cancer in the Sentinel Lymph Node Era
Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer
Effect of Cardiac Dysfunction on Treatment Outcomes in Women Receiving Trastuzumab for HER2-Overexpressing Metastatic Breast Cancer
Ductal Lavage Using Medically Aseptic Technique in Women at High Risk for Breast Cancer
Neoadjuvant FEC 100 for Operable Breast Cancer: Eight-Year Experience at Centre Jean Perrin
Selection Criteria for Accelerated Partial-Breast Irradiation: Impact on Applicability
A Method for Making Estimates of the Benefit of the Late Use of Letrozole in Patients Completing 5 Years of Tamoxifen
Paclitaxel Chemotherapy in a Pregnant Patient with Bilateral Breast Cancer